跳转至内容
Merck
  • Sodium oxybate intolerance associated with familial serum acylcarnitine elevation.

Sodium oxybate intolerance associated with familial serum acylcarnitine elevation.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine (2013-01-16)
Jon Berner
摘要

Our case describes clinical features of two families defined by joint phenotypes: sodium oxybate intolerance and elevated serum acylcarnitines. Oxybate intolerance variably presents as either cervical dystonia or sleep-related eating disorder. Our objective is to identify biological markers which predict a poor response to sodium oxybate as a treatment for disturbed sleep. Familial inheritance pattern, genotype analysis, multiorgan system involvement, and response to treatment suggest the presence of a secondary cause of fatty oxidation defect, i.e., mitochondrial disorder. Our case report supports the possible conclusion that variance in human mitochondrial metabolism may affect sodium oxybate tolerability.